Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 4/20 | 0.46 |
| ▸ | CA1 | P00915 | 3/20 | 0.46 |
| ▸ | CA7 | P43166 | 1/20 | 0.46 |
| ▸ | CA13 | Q8N1Q1 | 1/20 | 0.46 |
| ▸ | DNM1 | Q05193 | 7/20 | 0.44 |
| ▸ | APAF1 | O14727 | 1/20 | 0.41 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.41 |
| ▸ | RAD52 | P43351 | 1/20 | 0.41 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.41 |
| ▸ | BBOX1 | O75936 | 1/20 | 0.39 |
| ▸ | ENPP2 | Q13822 | 3/20 | 0.39 |
| ▸ | MEN1 | O00255 | 2/20 | 0.35 |
| ▸ | NFKB1 | P19838 | 2/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.35 |
| ▸ | APEX1 | P27695 | 2/20 | 0.35 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.35 |
| ▸ | LMNA | P02545 | 1/20 | 0.35 |
| ▸ | ACHE | P22303 | 1/20 | 0.35 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.35 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Trifluoromethanesulfonamide SCHEMBL1702592 | 0.92 | DNM1 (0.58) | CA2CA1CA7CA13DNM1 | |
| Trifluoromethanesulfonamide SCHEMBL6436451 | 0.92 | DNM1 (0.58) | CA2CA1CA7CA13DNM1 | |
| Tributylmethylammonium SCHEMBL28981157 | 0.88 | CA2 (0.46) | CA2CA1CA7CA13DNM1 | |
| Trifluoromethanesulfonamide SCHEMBL4359429 | 0.87 | CA2 (0.50) | CA2CA1CA7CA13DNM1 | |
| Trifluoromethanesulfonic Acid SCHEMBL10660719 | 0.83 | BBOX1 (0.48) | DNM1APAF1HSP90AA1RAD52EPHX1 | |
| Trifluoromethanesulfonic Acid SCHEMBL10660726 | 0.83 | DNM1 (0.44) | DNM1APAF1HSP90AA1RAD52EPHX1 | |
| Trifluoromethanesulfonamide SCHEMBL3315782 | 0.82 | CA2 (0.44) | CA2CA1CA7CA13BBOX1 | |
| SCHEMBL28176552 | 0.81 | DNM1 (0.48) | CA2DNM1APAF1HSP90AA1RAD52 | |
| SCHEMBL28177458 | 0.81 | DNM1 (0.48) | CA2DNM1APAF1HSP90AA1RAD52 | |
| SCHEMBL925224 | 0.80 | DNM1 (0.41) | DNM1APAF1HSP90AA1RAD52EPHX1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9452425-B2 | Compositions containing ionic liquids and their uses, in particular in organic synthesis | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) | 2016-09-27 | — | — | US | disclosed |
| US-20090326228-A1 | COMPOSITIONS CONTAINING IONIC LIQUIDS AND THEIR USES, IN PARTICULAR IN ORGANIC SYNTHESIS | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) | 2009-12-31 | — | — | US | disclosed |
| US-20060128996-A1 | Compositions containing Ionic liquids and uses thereof, especially in organic synthesis | UNIVERSITE DE RENNES 1 (FR) | 2006-06-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060128996-A1 | Compositions containing Ionic liquids and uses thereof, especially in organic synthesis | F12, ANXA1, OLA1 | CA2 182/4885CA1 78/4885CA7 656/4885 |
| US-20090326228-A1 | COMPOSITIONS CONTAINING IONIC LIQUIDS AND THEIR USES, IN PARTICULAR IN ORGANIC SYNTHESIS | F12, ANXA1, F11 | CA2 209/4885CA1 79/4885CA7 644/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.